ENTITY
NeoGenomics Inc

NeoGenomics Inc (NEO US)

17
Analysis
Health CareUnited States
NeoGenomics, Inc. operates a network of clinical laboratories that specializes in cancer genetics diagnostic testing services. The Company's services include cytogenetics, fluorescence in-situhybridization (FISH), flow cytometry, morphology, anatomic pathology, and molecular genetic testing. NeoGenomics serves pathologists, oncologists, urologists, and hospitals.
more
bullishOpko Health Inc
10 Mar 2022 18:39

Opko Health (OPK US): Diagnostic Business on Solid Grip; Pharmaceutical Business Ready to Take-Off

Opko Health’s pharmaceutical business is set to see couple of product launches in the international markets, while its diagnostic business is on a...

Logo
317 Views
Share
bullishS&P 500 INDEX
08 Aug 2018 04:51

S&P 500: Outlook Constructive but Concerns Remain

As the S&P 500 nears the 2,873 January high - a critical hurdle - short-term Sector leadership changes give us reason for pause. While we...

Logo
306 Views
Share
bullishS&P 500 INDEX
11 Jul 2018 21:09

U.S. Equity Strategy: XLF Support Holding; Large-Cap Health Care Perks Up

The S&P 500 is poised to retest the 2,790-2,800 horizontal resistance level that we have highlighted in previous reports. A bullish short-term...

Logo
491 Views
Share
05 Jan 2018 09:35

Human Longevity

At KIS capital we try to keep ourselves at the forefront of technology and innovation, attempting to identify which industries may blossom, and...

Share
x